文献速递胸部MR

使用0.55 T MRI评估淋巴管肌瘤病患者的肺结构和区域功能

Assessment of Lung Structure and Regional Function Using 0.55 T MRI in Patients With Lymphangioleiomyomatosis.
PubMed 文献 · Invest Radiol · 2022-01-01

在65例淋巴管肌瘤病患者中,采用原型0.55 T MRI系统进行T2加权成像计算囊变评分,并用氧增强MRI评估区域肺功能;囊变评分与CT测量强相关(R=0.86,P<0.0001),低氧增强区域百分比与FEV1、FEV1/FVC及囊变评分呈弱但显著相关。

要点

  • 0.55 T MRI的T2加权图像可显示LAM的肺囊性病变,囊变评分与CT测量强相关(R=0.86,P<0.0001)。
  • 氧增强MRI可显示LAM患者肺功能的区域缺损,且同一患者不同囊变之间氧增强存在异质性。
  • 低氧增强区域百分比与FEV1(R=-0.37,P=0.007)、FEV1/FVC(R=-0.33,P=0.02)及囊变评分(R=0.40,P=0.02)呈弱但显著相关。

核心结论

  • 使用高性能0.55 T MRI可同时对LAM患者的肺结构和区域功能进行成像。

研究设计与样本

  • 在65例淋巴管肌瘤病患者中,使用原型低场(0.55 T)MRI系统进行肺部成像;T2加权成像评估形态并计算囊变评分,氧增强MRI(屏气超短回波时间成像,吸入100%氧气作为T1缩短对比剂)评估区域肺功能,并与2天内进行的整体肺功能检查结果进行相关性分析。

关键影像表现/征象

  • T2加权MRI可显示LAM患者的肺囊性异常,并计算囊变评分(囊变占肺实质的百分比)。
  • 氧增强图显示LAM患者肺功能的区域缺损。
  • 同一患者不同囊变之间观察到氧增强的异质性。

诊断标准与关键数值

  • 囊变评分与CT测量强相关(R=0.86,P<0.0001)。
  • 低氧增强区域百分比与FEV1呈弱但显著相关(R=-0.37,P=0.007)。
  • 低氧增强区域百分比与FEV1/FVC呈弱但显著相关(R=-0.33,P=0.02)。
  • 低氧增强区域百分比与囊变评分呈弱但显著相关(R=0.40,P=0.02)。
  • 常氧与高氧之间测得的动脉血ΔT1(作为血中溶解氧的替代指标)与DLCO相关(R=-0.28,P=0.03)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Contemporary lower-field magnetic resonance imaging (MRI) may offer advantages for lung imaging by virtue of the improved field homogeneity. The aim of this study was to evaluate the utility of lower-field MRI for combined morphologic imaging and regional lung function assessment. We evaluate low-field MRI in patients with lymphangioleiomyomatosis (LAM), a rare lung disease associated with parenchymal cysts and respiratory failure.

MATERIALS AND METHODS: We performed lung imaging on a prototype low-field (0.55 T) MRI system in 65 patients with LAM. T2-weighted imaging was used for assessment of lung morphology and to derive cyst scores, the percent of lung parenchyma occupied by cysts. Regional lung function was assessed using oxygen-enhanced MRI with breath-held ultrashort echo time imaging and inhaled 100% oxygen as a T1-shortening MR contrast agent. Measurements of percent signal enhancement from oxygen inhalation and percentage of lung with low oxygen enhancement, indicating functional deficits, were correlated with global pulmonary function test measurements taken within 2 days.

RESULTS: We were able to image cystic abnormalities using T2-weighted MRI in this patient population and calculate cyst score with strong correlation to computed tomography measurements (R = 0.86, P < 0.0001). Oxygen-enhancement maps demonstrated regional deficits in lung function of patients with LAM. Heterogeneity of oxygen enhancement between cysts was observed within individual patients. The percent low-enhancement regions showed modest, but significant, correlation with FEV1 (R = -0.37, P = 0.007), FEV1/FVC (R = -0.33, P = 0.02), and cyst score (R = 0.40, P = 0.02). The measured arterial blood ΔT1 between normoxia and hyperoxia, used as a surrogate for dissolved oxygen in blood, correlated with DLCO (R = -0.28, P = 0.03).

CONCLUSIONS: Using high-performance 0.55 T MRI, we were able to perform simultaneous imaging of pulmonary structure and regional function in patients with LAM.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Bhattacharya I, Ramasawmy R, Javed A, et al. Assessment of Lung Structure and Regional Function Using 0.55 T MRI in Patients With Lymphangioleiomyomatosis. Invest Radiol. 2022. PMID: 34652290. doi:10.1097/RLI.0000000000000832

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。